Cite
HARVARD Citation
Silverberg, J. et al. (n.d.). 359 Switching from dupilumab to abrocitinib in patients with moderate-to-severe atopic dermatitis: an analysis of responders and nonresponders to dupilumab. British journal of dermatology. p. . [Online].